Literature DB >> 19786430

Relationship of serum S100B levels and intracranial injury in children with closed head trauma.

Kirsten Bechtel1, Sarah Frasure, Clement Marshall, James Dziura, Christine Simpson.   

Abstract

OBJECTIVE: To determine if serum levels of S100B are higher in children with CHT and ICI as detected by cranial CT and if long bone fractures affect the level of S100B in children with CHT and skeletal injury.
METHODS: Children <18 years of age who presented to an urban pediatric emergency department or were transferred from a referral hospital within 6 hours after accidental closed head trauma and who underwent cranial computed tomography were enrolled prospectively. Mean serum S100B levels for children with or without intracranial injury (ICI) and long-bone fractures were evaluated through analysis of covariance.
RESULTS: One hundred fifty-two children, 24 with ICI and 128 without ICI, were enrolled prospectively. Twenty-five children had long-bone fractures. Children with ICI were significantly younger than those without ICI (6.9 vs 9.8 years; P = .01). The time of venipuncture after injury was significantly later in children with ICI (P = .03). Mean S100B levels were significantly greater for children with ICI (212.9 vs 84.4 ng/L; P = .001), children with long-bone fractures (P = .008), and nonwhite children (P = .03). After controlling for time of venipuncture, long-bone fractures, and race, mean S100B levels were still greater for children with ICI (409 vs 118 ng/L; P = .001). The ability of serum S100B measurements to detect ICI, determined as the area under the curve, was 0.67.
CONCLUSIONS: After controlling for time of venipuncture, long-bone fractures, and race, S100B levels were still higher in children with ICI than in those without ICI. However, the ability of serum S100B measurements to detect ICI was poor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786430     DOI: 10.1542/peds.2008-1493

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Neuron-specific enolase, but not S100B or myelin basic protein, increases in peripheral blood corresponding to lesion volume after cortical impact in piglets.

Authors:  Beth A Costine; Patricia B Quebeda-Clerkin; Carter P Dodge; Brent T Harris; Simon C Hillier; Ann-Christine Duhaime
Journal:  J Neurotrauma       Date:  2012-09-27       Impact factor: 5.269

Review 2.  [Biomarkers in pediatric polytrauma].

Authors:  H Andruszkow; R Pfeifer; K Horst; P Kobbe; H-C Pape; F Hildebrand
Journal:  Unfallchirurg       Date:  2014-08       Impact factor: 1.000

3.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Authors:  Linda Papa; Salvatore Silvestri; Gretchen M Brophy; Philip Giordano; Jay L Falk; Carolina F Braga; Ciara N Tan; Neema J Ameli; Jason A Demery; Neha K Dixit; Matthew E Mendes; Ronald L Hayes; Kevin K W Wang; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2014-09-12       Impact factor: 5.269

4.  Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.

Authors:  Rachel P Berger; Ronald L Hayes; Rudolph Richichi; Sue R Beers; Kevin K W Wang
Journal:  J Neurotrauma       Date:  2012-01-01       Impact factor: 5.269

Review 5.  Biomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature.

Authors:  Jennifer C Munoz Pareja; Xue Li; Nithya Gandham; Kevin K Wang
Journal:  Pediatr Neurol       Date:  2022-03-18       Impact factor: 3.372

6.  In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.

Authors:  Linda Papa; Manoj K Mittal; Jose Ramirez; Michelle Ramia; Sara Kirby; Salvatore Silvestri; Philip Giordano; Kurt Weber; Carolina F Braga; Ciara N Tan; Neema J Ameli; Marco Lopez; Mark Zonfrillo
Journal:  J Neurotrauma       Date:  2015-06-03       Impact factor: 5.269

7.  Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest*.

Authors:  Ericka L Fink; Rachel P Berger; Robert S B Clark; Robert S Watson; Derek C Angus; Rudolph Richichi; Ashok Panigrahy; Clifton W Callaway; Michael J Bell; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

8.  Serum Biomarkers of Regeneration and Plasticity are Associated with Functional Outcome in Pediatric Neurocritical Illness: An Exploratory Study.

Authors:  Catherine Madurski; Jessica M Jarvis; Sue R Beers; Amy J Houtrow; Amy K Wagner; Anthony Fabio; Chunyan Wang; Craig M Smith; Lesley Doughty; Keri Janesko-Feldman; Pamela Rubin; Dorothy Pollon; Amery Treble-Barna; Patrick M Kochanek; Ericka L Fink
Journal:  Neurocrit Care       Date:  2021-03-04       Impact factor: 3.532

Review 9.  Systematic review of clinical research on biomarkers for pediatric traumatic brain injury.

Authors:  Linda Papa; Michelle M Ramia; Jared M Kelly; Stephen S Burks; Artur Pawlowicz; Rachel P Berger
Journal:  J Neurotrauma       Date:  2013-02-15       Impact factor: 5.269

10.  Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.

Authors:  Stefania Mondello; Firas Kobeissy; Annarita Vestri; Ronald L Hayes; Patrick M Kochanek; Rachel P Berger
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.